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Abstract
Background: Osteoporosis is defined as the loss of bone mineral density that leads to bone
fragility with aging. Population-based case-control studies have identified polymorphisms in many
candidate genes that have been associated with bone mass maintenance or osteoporotic fracture.
To investigate single nucleotide polymorphisms (SNPs) that are associated with osteoporosis, we
examined the genetic variation among Koreans by analyzing 81 genes according to their function in
bone formation and resorption during bone remodeling.
Methods: We resequenced all the exons, splice junctions and promoter regions of candidate
osteoporosis genes using 24 unrelated Korean individuals. Using the common SNPs from our study
and the HapMap database, a statistical analysis of deviation in heterozygosity depicted.
Results: We identified 942 variants, including 888 SNPs, 43 insertion/deletion polymorphisms, and
11 microsatellite markers. Of the SNPs, 557 (63%) had been previously identified and 331 (37%)
were newly discovered in the Korean population. When compared SNPs in the Korean population
with those in HapMap database, 1% (or less) of SNPs in the Japanese and Chinese subpopulations
and 20% of those in Caucasian and African subpopulations were significantly differentiated from the
Hardy-Weinberg expectations. In addition, an analysis of the genetic diversity showed that there
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were no significant differences among Korean, Han Chinese and Japanese populations, but African
and Caucasian populations were significantly differentiated in selected genes. Nevertheless, in the
detailed analysis of genetic properties, the LD and Haplotype block patterns among the five sub-
populations were substantially different from one another.
Conclusion: Through the resequencing of 81 osteoporosis candidate genes, 118 unknown SNPs
with a minor allele frequency (MAF) > 0.05 were discovered in the Korean population. In addition,
using the common SNPs between our study and HapMap, an analysis of genetic diversity and
deviation in heterozygosity was performed and the polymorphisms of the above genes among the
five populations were substantially differentiated from one another. Further studies of osteoporosis
could utilize the polymorphisms identified in our data since they may have important implications
for the selection of highly informative SNPs for future association studies.
Background
Bone is continuously remodeled in vertebrates through
coordinated phases of bone formation and resorption in
order to maintain bone volume and phosphorus and cal-
cium homeostasis [1]. Bone remodeling by direct contact
with bone cells or by the release of soluble effectors is also
altered by other cell protagonists present in the bone
microenvironment such as monocytes/macrophages,
lymphocytes, and endothelial cells [2]. In the disease
state, the loss of bone homeostasis is potentially associ-
ated with changes in the numerous cellular protagonists
that are responsible for the interactions between bone tis-
sue, the immune system, and the vascular compartment.
The study of bone homeostasis can therefore be utilized to
elicit a better understanding of the pathologies associated
with bone diseases such as osteoporosis [2]. Bone mass
also has a very strong genetic determination: Twin and
family studies showed that genetic factor could cause 50
to 90% of variance in bone mineral density (BMD) [3-8].
In addition, both the calcium-sensing receptor (CASR)
and the interleukin 6 (IL-6) are important candidate genes
for osteoporosis as well as in bone and mineral metabo-
lism. These genes may have effects on BMD variation in
Chinese nuclear families [9]. Determining SNPs for bone
remodeling-related genes is becoming a more feasible and
efficient tool for analyzing the processes associated with
osteoporosis. However, an investigation of the distribu-
tion of SNPs within human populations is laborious and
costly, mainly due to the necessity of testing large num-
bers of individuals and SNPs. Some SNPs for bone remod-
eling genes have already been reported; however, there are
significant differences in allele frequency distributions
among population groups, indicating that the popula-
tions exhibit genetic heterogeneity with respect to the inci-
dence of these SNPs. Moreover, racial differences in the
prevalence of certain alleles could account for a certain
proportion of bone disease trait variation between differ-
ent ethnicities [10]. The genetic variability of Asian and
Caucasian populations was observed at restriction sites
exhibiting polymorphisms of five important candidate
genes for BMD: CASR-BsaHI, alpha 2HS-glycoprotein
(AHSG)-SacI, estrogen receptor alpha (ESR1)-PvuII and
XbaI, vitamin D receptor (VDR)-ApaI and parathyroid hor-
mone (PTH)-BstBI. The results of the statistical analysis
between the two populations revealed a significant allelic
and genotypic differentiation in polymorphisms associ-
ated with osteoporosis. Intra- and inter-population varia-
bility implies that the studied pattern of variation at some
loci may be affected by various types of natural selection
[11]. A case-control approach is normally used to investi-
gate the association of osteoporosis with SNPs in oste-
oporosis-related genes. A few of the newly discovered
candidate genes (PLXNA2, CAT and  SEMA7A) in our
study were also used in case-control association studies in
a Korean population [12-14]. These genes were screened
in 24 individuals and then were genotyped in 560 post-
menopausal women to compare gene and bone proper-
ties. Statistical analyses found a genetic linkage of the
SNPs and haplotypes from the above genes with a risk of
vertebral fracture or with BMD at the lumbar spine and at
the femur neck [12-14]. Thus, to facilitate further associa-
tion studies using SNPs of genes involved in osteoporosis,
we selected 81 candidate genes involved in bone forma-
tion and resorption. We have characterized the genetic
variants of these candidate osteoporosis genes, including
gene-based haplotype diversity. These SNPs may be useful
for genetic association studies that compare the SNP and
haplotype information of ethnic groups.
Methods
Subjects and candidate genes
The study population consists of 24 unrelated Korean
individuals, 11 men and 13 women, who were recruited
from Ansan and Ansung area. The men were aged between
41 and 65 years (mean ± SD: 57.8 ± 8.5 years) and the
women were aged between 41 and 62 years (mean ± SD:
52.6 ± 6.9 years). They were used for SNP screening and
immortalized B lymphocyte cell line generation (cell line
IDs GRB2015717, GRB2014744, GRB2014719,
GRB2014754, GRB2015301, GRB2014712,
GRB2012585, GRB2012949, GRB2012816,
GRB2013123, GRB2012811, GRB2012998,BMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
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GRB2015263, GRB2014890, GRB2014112,
GRB2014896, GRB2014197, GRB2010947,
GRB2021291, GRB2021404, GRB2021105,
GRB2022466, GRB2026940, GRB2021302). Informed
consent was obtained from all of the subjects, and this
study was approved by the Institutional Review Board of
the Korea National Institute of Health. Candidate oste-
oporosis genes were selected based on their function in
bone/chondrocyte formation or bone resorption accord-
ing to reports in the literature. We included the following
genes of interest: those that promote or inhibit bone/
chondrocyte formation; those that promote or inhibit
bone resorption; and those involved in adipocyte differ-
entiation. Genes of interest that promote bone/chondro-
cyte formation are as follows: FGFs [15], SOX5,6,9 [15],
BMPs  [16],  LGALS3  [17],  LGALS1  [18],  DLX5  [16,19],
MSX2 [19], SP7 [19], CBFB [20], TGFBI [21], MSX1 [22],
BGLAP [23], SPP1 [24], IBSP [24], IL1RN [25], CTNNB1
[16,26], WNTs [26], TCF4 [27], OMD [28], VEGFs [29],
DMP1 [30], IL13  [31], AR  [32], CYP17A1  [32,33] and
CYP19A1  [32,33]. Genes of interest that inhibit bone/
chondrocyte formation are as follows: PTHrP/PTHR1
[15,19], NPY2R [19], PPARG [19], TWIST1 [16,24], DKK1
[26], PTH [19,34], AHSG [35], PPP3CA [36], WIF1 [37],
MEPE [38] and IL10 [39,40]. Genes of interest that pro-
mote bone resorption are as follows: PTHrP/PTHR1
[15,19], PTH [19,34], PTGS2 [26], IL4 [34], IL6ST [41],
CTSK [42], H+ATPase [42], ITGA1 [42,43], NFKB [42,44],
CALCR [44], CLCN7 [44], FOS [44,45], FOSB [42,45],
FOSL2 [46,47], ITGAV [42,44], CSK [42], TRAF6 [42,44],
MITF  [44],  CCR1  [48],  NFATC1  [49],  JDP2  [50],  IL15
[51], PTK2B [52], CASR [53], SEMA7A [54], PTGER4 [55]
and  PLXNA2  [12]. Genes of interest that inhibit bone
resorption are as follows: IL13 [31], AR [32], IL3 [56],
ZNF675 [57], GPX1 [58] and CAT [59]. In additional, a
decrease in bone volume that occurs with age and in oste-
oporosis is accompanied by an increase in adipose tissue
in the bone marrow, suggesting a dysregulation of the
mesenchymal stem cell differentiation pathway in favour
of adipogenesis. Therefore, we also included the following
adipocyte differentiation genes: PPARs  [19],  CEBPB
[19,47] and DBI [60].
Resequencing analysis
To identify SNPs in the 81 candidate osteoporosis genes
(Table 1), we resequenced all exons, including the coding
region, the 5' UTR and the 3' UTR up to the splice junc-
tions, as well as the promoter regions of approximately
0.5 kb proximal to the transcription start site in genomic
DNA samples. For sequencing analysis, genomic DNA
information was obtained from GenBank. Polymerase
chain reaction (PCR) primers were designed using the
Primer 3 program [61]. Genomic DNA was isolated from
the 24 immortalized B lymphocyte cell lines of the
selected subjects. PCR products were sequenced using the
BigDye Terminator v3.1 cycle sequencing kit (Applied
Biosystems, Foster City, CA) and an ABI 3730 automated
sequencer (Applied Biosystems). SNPs were detected by
multiple alignments of the sequences using the Phred/
Phrap/Consed package [62,63] and polyphred [64]. All
data for the SNPs discovered in the Korean samples have
been deposited in the KSNP database [65].
Statistical analysis
The HapMap database [66] was used to compare the
Korean population with other populations. To measure
the genetic differentiation between populations, Wright's
FST (the classic measure of population divergence) was cal-
culated from the genotypic data. Haplotypes were sug-
gested using the Partition Ligation-Expectation
Maximization (PL-EM) algorithm [67]. We used the KSNP
database to analyze LD and haplotype blocks and for tag-
ging the detected SNPs. We defined LD blocks according
to the method of LD-based blocking with bootstrapping
[68], and haplotype tagging of selected SNPs was accom-
plished using the Entropy method [69].
Results
Identification of SNPs in candidate osteoporosis genes in 
the Korean population
We directly sequenced 81 candidate osteoporosis genes
including all exons, their intron boundaries, and ~1.5 kb
of the 5' flanking region. We identified 942 variants,
including 888 SNPs, 43 insertion/deletion polymor-
phisms, and 11 microsatellite markers (Table 2). Of the
888 SNPs, 118 were located in promoter regions, 21 in 5'
untranslated regions (UTRs), 157 in coding regions, 435
in introns, 119 in 3' UTRs and 38 in intergenic regions
(Table 2). With regard to the minor allele frequency
(MAF), we classified the 888 SNPs into low (MAF < 0.05),
intermediate (0.05–0.15), and high (>0.15) frequency
classes as described by Cargill et al [70] (Fig. 1A). Of the
888 SNPs, we identified 331 unknown SNPs which were
not reported in dbSNP (build 124), and the rest were
known (Fig. 1B). Of the 888 SNPs, 401 belonged to the
high MAF class, of which 53 (13.2%) were unknown
SNPs. In addition, the majority of the low MAF class
(70.3%) were also unknown SNPs, suggesting that a large
portion of newly identified SNPs exist in a recessive
model. Overall, about two-third of the SNPs identified in
this study are common in the Korean population (MAF >
0.05). When functionally classified, 76% of the nonsyn-
onymous SNPs (cSNP) belonged to the low MAF class
whereas only 52.2% of SNPs in the promoter regions
belonged to this class (Fig. 1C). In addition, newly identi-
fied SNPs with MAF > 0.15 represented 16% of all the dis-
covered SNPs. In functional aspect, we found some
unknown SNPs in the coding region of the genes encod-
ing interleukin 6 signal transducer (IL6ST), the androgen
receptor (AR), and the core-binding factor beta subunitBMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
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Table 1: Gene information for candidate osteoporosis genes
Gene Symbol Gene Name Locus ID NM_# Genomic Size Exon #
BGLAP Bone gamma-carboxyglutamate (gla) protein (osteocalcin) 1q25-q31 NM_000711 263037 8
CALCR Calcitonin receptor 7q21.3 NM_001742 149952 13
IL6ST Interleukin 6 signal transducer (gp130, oncostatin M receptor) 5q11 NM_002184 54069 17
LGALS3 Lectin, galactoside-binding, soluble, 3 (galectin 3) 14q21-q22 NM_002306 16124 6
PPARG Peroxisome proliferative activated receptor, gamma 3p25 NM_005037 146417 7
PTH Parathyroid hormone 11p15.3-p15.1 NM_000315 3966 3
SP7 Sp7 transcription factor(osterix) 12q13.13 NM_152860 9176 2
TGFBI Transforming growth factor, beta-induced, 68 kDa 5q31 NM_000358 34810 17
AR Androgen receptor Xq11.2-q12 NM_000044 180246 8
BMP7 Bone morphogenetic protein 7 20q13 NM_001719 95747 7
AHSG Alpha 2 HS-glycoprotein 3q27 NM_001622 8219 7
BMP2 Bone morphogenetic protein 2 20p12 NM_001200 10563 3
BMP4 Bone morphogenetic protein 4 14q22-q23 NM_001202 7156 4
BMP6 Bone morphogenetic protein 6 6p24-p23 NM_001718 154718 7
CBFB Core-binding factor, beta subunit 16q22.1 NM_022845 71907 6
CTSK Cathepsin K 1q21 NM_000396 12126 8
DLX5 Distal-less homeobox 5 7q22 NM_005221 4436 3
IBSP Integrin-binding sialoprotein (bone sialoprotein, bone sialoprotein 
II)
4q21-q25 NM_004967 12373 7
IL1RN Interleukin 1 receptor antagonist 2q14.2 NM_000577 16123 5
LGALS1 Lectin, galactoside-binding, soluble, 1 (galectin 1) 22q13.1 NM_002305 4165 4
MSX1 Msh homeobox homolog 1 4p16.3-p16.1 NM_002448 4053 3
MSX2 Msh homeobox homolog 2 5q34-q35 NM_002449 6300 2
PTHLH Parathyroid hormone-like hormone 12p12.1-p11.2 NM_002820 9663 4
PTHR1 Parathyroid hormone receptor 1 3p22-p21.1 NM_000316 26052 16
RUNX1 Runt-related transcription factor 1 21q22.3 NM_001754 261497 8
SPP1 Secreted phosphoprotein 1 (osteopontin, bone sialoprotein I) 4q21-q25 NM_000582 7761 6
TWIST1 Twist homolog 1 (acrocephalosyndactyly 3; Saethre-Chotzen 
syndrome)
7p21.2 NM_000474 2203 2
CEBPB CCAAT/enhancer binding protein (C/EBP), beta 20q13.1 NM_005194 1837 1
CYP17A1 Cytochrome P450, family 17, subfamily A, polypeptide 1 10q24.3 NM_000102 6885 8
CYP19A1 Cytochrome P450, family 19, subfamily A, polypeptide 1 15q21.1 NM_000103 129125 10
IL10 Interleukin 10 1q31-q32 NM_000572 4892 5
IL4 Interleukin 4 5q31.1 NM_000589 5996 4
NFKB1 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 
(p105)
4q24 NM_003998 115989 24
VEGF Vascular endothelial growth factor 6p12 NM_003376 14391 8
NPY2R Neuropeptide Y receptor Y2 4q31 NM_000910 8447 2
FGF2 Fibroblast growth factor 2 4q26-q27 NM_002006 71528 3
FOS V-fos FBJ murine osteosarcoma viral oncogene homolog 14q24.3 NM_005252 3383 4
FOSB FBJ murine osteosarcoma viral oncogene homolog B 19q13.32 NM_006732 7184 4
SOX5 SRY (sex determining region Y)-box 5 12p12.1 NM_152989 1030149 18
SOX6 SRY (sex determining region Y)-box 6 11p15.3 NM_033326 506124 16
SOX9 SRY (sex determining region Y)-box 9 17q24.3-q25.1 NM_000346 5401 3
PTGER4 Prostaglandin E receptor 4 (subtype EP4) 5p13.1 NM_000958 13804 3
CSK C-src tyrosine kinase 15q23-q25 NM_004383 20790 13
FGF23 Fibroblast growth factor 23 12p13.3 NM_020638 11502 3
FOSL2 Fos-like antigen 2 2p23-p22 NM_005253 21736 4
REL V-rel reticuloendotheliosis viral oncogene homolog (avian) 2p13-p12 NM_002908 41427 11
RELA V-rel reticuloendotheliosis viral oncogene homolog A, p65 (avian) 11q13 NM_021975 8559 11
RELB V-rel reticuloendotheliosis viral oncogene homolog B (avian) 19q13.32 NM_006509 36741 11
NFKB2 Nuclear factor of kappa light polypeptide gene enhancer in B-cells 2 
(p49/p100)
10q24 NM_002502 6805 23
ITGAV Integrin, alpha V (vitronectin receptor, alpha polypeptide, antigen 
CD51)
2q31-q32 NM_002210 90828 30
JDP2 Jun dimerization protein 2 14q24.3 NM_130469 38320 4
NFATC1 Nuclear factor of activated T-cells, cytoplasmic, calcineurin-
dependent 1
18q23 NM_172390 72406 8
PPP3CA Protein phosphatase 3 (formerly 2B), catalytic subunit, alpha 
isoform (calcineurin A alpha)
4q24 NM_000944 323767 14BMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
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(CBFB) which were not reported in dbSNP database.
However, there were no SNPs in the coding region of
NFKB2 in both our dataset and dbSNP, suggesting that
they are functionally and evolutionary highly conserved
genes.
It has been reported that the Japanese SNP database
(JSNP) was constructed through the gene-based resquenc-
ing method of 24 individuals [71]. Therefore, the newly
discovered SNPs for candidate genes of osteoporosis from
this study were compared with those in the JSNP database.
Of 70 SNPs in the exon region (excluding UTR) with MAF
> 0.05 in our data, 28 SNPs were common between our
study and the JSNP database. The ratio of the common
SNPs to all SNPs from our data and those from JSNP for
the selected genes was 28/70 and 28/43, respectively.
Deviation in Heterozygosity and Genetic diversity
We used HapMap to compare the allele frequencies of
diverse ethnic groups with that of the Korean population
[72]. Among the 557 known SNPs detected in this study,
313 were found in HapMap. We thus evaluated genetic
differences between Koreans and the diverse populations
by measuring the Wright's FST coefficients using the 313
common SNPs assuming the Hardy-Weinberg principle.
FIS is the average deviation in heterozygosity within sub-
populations, FST is the deviation due to subdivision alone,
and FIT is the overall deviation in heterozygosity in the
total population [73]. The mean values of FIS, FST and FIT
for multiple loci with five subpopulations (KR, CHB, JPT,
CEU and YRI) are -0.0121, 0.3366 and 0.3287, respec-
tively, indicating that the SNPs in genes associated with
osteoporosis were significantly differentiated among the
five subpopulations while the SNPs within the subpopu-
lations were consistent with the Hardy-Weinberg expecta-
tions. In addition, the pairwise FST (s) of KR compared
with each of the four subpopulations using the 313 indi-
vidual SNPs were calculated. The distribution of the pair-
wise FST (s) values is plotted in Fig. 2. Interestingly, two
distribution patterns were observed that grouped KR-CHB
with KR-JPT and KR-CEU with KR-YRI. In addition, the FST
values for KR-CHB and KR-JPT continually decreased to
0.05 whereas those of KR-CEU and KR-YRI continued to
0.2 or more from which point the overall major and
minor alleles are reversed, suggesting that there is a large
genetic barrier among continental populations. When a
threshold (FST = 0.1 or higher) as the level of significance
was applied [74] to our data, 2, 2, 73 and 92 out of 313
SNPs were significantly deviated between KR compared
with CHB, JPT, YRI and CEU, respectively. In order to
investigate the difference in linkage disequilibrium (LD)
patterns between the significantly diverse SNPs in the sub-
populations, two highly polymorphic genes (PTK2B and
IL1RN) in terms of the number of SNPs per gene were
CASR Calcium sensing receptor 3q21.1 NM_000388 102813 7
ZNF675 Zinc finger protein 675 19p12 AB_209601 33969 4
TRAF6 TNF receptor associated factor 6 11p12 NM_004620 21100 7
CLCN7 Chloride channel 7 16p13.3 NM_001287 29668 25
DBI Diazepam binding inhibitor (acyl-Coenzyme A binding protein) 2q14.2 NM_020548 5461 5
CTNNB1 Catenin (cadherin-associated protein), beta 1, 88 kDa 3p21 NM_001904 40935 15
TCF4 Transcription factor 4 18q21.2 NM_003199 360475 20
OMD Osteomodulin 9q22.31 NM_005014 10023 3
DMP1 Dentin matrix acidic phosphoprotein 4q22.1 NM_004407 14049 6
WIF1 WNT inhibitory factor 1 12q14.3 NM_007191 70681 10
MEPE Matrix extracellular phosphoglycoprotein with ASARM motif (bone) 4q22.1 NM_020203 13807 4
CCR1 Chemokine (C-C motif) receptor 1 3p21.31 NM_001295 6101 2
ATP6V0D2 ATPase, H+ transporting, lysosomal 38 kDa, V0 subunit d2 8q21.3 NM_152565 55316 8
IL15 Interleukin 15 4q31.21 NM_172174 96859 8
VEGFC Vascular endothelial growth factor C 4q34.3 BC_063685 109205 7
PTK2B PTK2B protein tyrosine kinase 2 beta 8p21.2 NM_004103 147905 35
WNT9A Wingless-type MMTV integration site family, member 9A 1q42.13 NM_003395 26903 4
PPARA Peroxisome proliferative activated receptor, alpha 22q13.31 NM_001001
928
93155 8
CAT Catalase 11p13 NM_001752 33115 13
GPX1 Glutathione peroxidase 1 3p21.3 NM_201397 1181 1
ITGA1 Integrin, alpha 1\ 5q11.2 NM_181501 165350 29
MITF Microphthalmia-associated transcription factor 3p14.2-p14.1 NM_198159 228855 10
PLXNA2 Plexin A2 1q32.2 NM_025179 216898 32
PTGS2 Prostaglandin-endoperoxide synthase 2 1q25.2-q25.3 NM_000963 8588 10
SEMA7A Semaphorin 7A, GPI membrane anchor 15q22.3-q23 NM_003612 23954 14
DKK1 Dickkopf homolog 1 10q11.2 NM_012242 3063 4
IL3 Interleukin 3 (colony-stimulating factor, multiple) 5q31.1 NM_000588 2550 5
IL13 Interleukin 13 5q31 NM_002188 2937 4
Table 1: Gene information for candidate osteoporosis genes (Continued)BMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
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Table 2: Summary of polymorphisms discovered in candidate osteoporosis genes
Gene IND MIC SNP
Promoter 5'UTR Syn Nonsyn 3'UTR Intron Intergenic Total
aT bN TNTNTNTNTNTNTNT NTN
B G L A P 1 11 21
C A L C R 32 1 1 4231 93
I L 6 S T 1 1 1 12 15 5 9 8
L G A L S 3 1131 41 83
P P A R G 22 1 1 32 52
P T H 1 111 31
SP7 1 1 0
TGFBI 5 1 2 12 4 19 5
A R 22551144 1 11 3 1 3
BMP7 17 1 8 1
AHSG 2 2 2 6 0
BMP2 1 3 1 1 5 1
BMP4 1 9 5 10 5
B M P 6 21112141 94
C B F B 115544 1 0 1 0
C T S K 11 11 22
D L X 5 11 11 22
IBSP 2 2 2 5 9 2
IL1RN 4 1 3 1 1 24 1 34 1
LGALS1 1 4 2 5 2
MSX1 1 2 1 2 1
M S X 2 111 2 20
PTHLH 1 1 1 1 2 1 4 2
PTHR1 1 1 1 4 6 1
RUNX1 11 10 3 1 14 11
S P P 1 6 5 2 3172 1 8 8
TWIST1 2 2 1 1 1 2 1
FGF2 6121 1 1 93
FOS 1 1 2 1 1 5 0
F O S B 1 1 311 52
C S K 32 3 33 95
P T G E R 4 2 1 22 43
FGF23 2 1 2 1
FOSL2 1 1 2 3 1
ITGAV 1 3 1 14 7 18 8
REL 1 1 2 1 3 2
RELA 22 0
R E L B 1 1 1 1131 53
S O X 5 11 22 112 53
S O X 6 21 86 1 0 7
SOX9 21 1 3 1
IL3 1 1 0
IL4 1 1 1 3 5 1
IL13 1 1 1 3 0
NFKB1 3 3 3 2 1 1 2 2 23 5 29 10
VEGF 3 3 1 2 10 3 6 1 19 4
I L 1 0 11 3152 83
N P Y 2 R 1111 2 1111 1 0 6 1 4 8
C A T 2 1 1 22 92 2 1 7 4
CEBPB 4 2 42
C Y P 1 7 A 1 2 1 3111 1 0 1 1 7 3
C Y P 1 9 A 1 21 2122 1 5 4 2 2 1 7
GPX1 1 1 2 0
I T G A 1 2 2 5 2 2 5 21 333 13 5 1 6 1 1 1
M I T F 4 2 115332 2 11 5 9BMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
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selected and their Haplotype blocks using Haploview
[75,76] were plotted against five subpopulations, KR,
CHB, JPT, CEU and YRI, as shown in Fig. 3. Interestingly,
all five haplotype blocks for each gene were different from
one another. Overall, the largest block was found in the
CEU population whereas smaller blocks were found in the
two genes of the KR and YRI populations. This result
implies that determining genetic properties, such as, LD is
a powerful method to elucidate the subtle differences in
genetic diversity between sub-populations.
In order to determine the genetic diversity between sub-
populations, both Nei's standard genetic distance and Lat-
ter's FST distance were also calculated [77,78] and listed in
Table 3. Overall, both distance measures agreed with each
other in terms of the trend, but overall, Nei's distances
were lower than those of Latter's. The genetic distance
between the KR and either the CHB (0.012) or the JPT
(0.013) subpopulations was very close to each other. On
the other hand, the genetic distance of the KR population
was closer to the YRI population (0.594) than that of the
CEU population (0.646) in these SNPs of selected genes.
Therefore, the genetic diversity between KR compared
with the other populations for the selected genes also
agreed with the FST analysis result.
Discussion
In this study, 81 candidate genes of osteoporosis were
sequenced to identify common genetic polymorphisms
that might alter bone remodeling. In the analysis of differ-
ences among ethnic group allele frequencies using the
measure of genetic distance, we showed that the Han Chi-
nese and Japanese populations were close to the Korean
population. This implies a strong genetic linkage among
the Han Chinese, Japanese and Korean populations,
which may reflect either a recent common ancestry or
high levels of mutual immigration among these groups
[79].
The 888 polymorphisms identified in this study were
obtained from 24 unrelated individuals. Three hundred
and thirty-one (37.3%) variants were newly identified
polymorphisms that were not present in the public data-
base examined, whereas 557 (62.7%) of the polymor-
phisms found by resequencing were already present in the
database. Of the 331 variants that were not reported in the
database, 64.4% belonged to the low minor allele fre-
P L X N A 2 1 5282 3 3 1 61 14 7 2 1
P T G S 2 2 4 13236 3 2 2 0
S E M A 7 A 1 1 51112 63 1 5 6
D K K 1 1 1 21 41
C A S R 22 2 1122312 51 1 5 5
C C R 1 22 11115 1 0 5 1 1 8 7
CLCN7 2 2 10 5 2 1 2 1 12 5 1 27 12
C T N N B 1 11 1 3131 72
D B I 1 14 11 41 1 1 7 6
DMP1 2 2 6 2 1 2 4 14 1
IL15 2 1 4 1 10 2 16 4
JDP2 2 1 2 5 0
MEPE 1 1 1 1 9 2 12 3
N F A T C 1 4 1 3 111196 1 8 9
O M D 4 1111 62
P P A R A 11112 1 1121 6 51 1 8
PPP3CA 11112 4375 1 3 8
PTK2B 8 4 3 1 10 3 1 1 24 6 3 2 50 16
T C F 4 1111 1 1 1 7 1 2 7
T R A F 6 33 3 1 1111 53
VEGFC 1 1 2 2 1 1 3 1 6 4
W I F 1 11114 4 1 31 85
W N T 9 A 2 2 3111 1 92
A T P 6 V 0 D 221113 11111 213 1 11 1 5
Z N F 6 7 5 111 22 43
Total 43 35 11 8 118 46 21 6 81 27 76 40 11
9
47 43
5
151 38 14 88
8
331
SNPs, single nucleotide polymorphisms; IND, insertion/deletion polymorphism; MIC, microsatellite; UTR, untranslated region. Syn, Synonymous 
cSNP, indicates there is no change in the amino acid; Nonsyn, Nonsynonymous cSNP, substitutions in coding regions that result in a different amino 
acid
aT, sum of known SNPs and newly identified SNPs; bN, newly identified SNP in this study
Table 2: Summary of polymorphisms discovered in candidate osteoporosis genes (Continued)BMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
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quency group (MAF < 0.05) in Koreans and variants,
35.6% were common SNPs in the Korean population.
These common SNPs could be useful for further case-con-
trol association studies of osteoporosis in Koreans. We
identified new SNPs that had low allele frequencies. This
may be due to the fact that previous studies used various
factors, such as a mixture of populations, or had a rela-
tively smaller sample size, thereby limiting their ability to
discover low allele frequency SNPs. Alternatively, as an
ethnically homogeneous population, the Korean samples
may have allele frequencies that significantly differ from
those from mixed samples. Of the 557 variants that were
already present in the dbSNP database, only 16.2% had a
minor allele frequency lower than 0.05, 21.4% between
0.05 to 0.15 and 62.5% greater than 0.15. Therefore, our
resequencing effort provided experimental validation for
more than 460 polymorphisms that were already in the
database.
In our study, we measured the LD block structure of the
candidate genes, excluding cases of one or two SNPs and
uncommon SNPs (MAF < 0.05) in each gene, from the
limited sample using normalized D' statistics between all
pairwise SNP markers with MAF > 0.05 that satisfied the
Hardy-Weinberg's equilibrium (p < 0.05). The LD and
haplotype results are shown in the KSNP database [65]. A
comparison of the haplotype blocks of two highly poly-
morphic genes (PTK2B and IL1RN) from the KR popula-
tion with those from the 4 subpopulations in HapMap,
showed diverse block patterns (Fig. 3). Therefore, the LD
and haplotype information could be valuable resources
for ethnicity comparison, tagging SNPs and recombina-
tion signals of the osteoporosis-related genes in future
studies.
In this study, the nonsynonymous cSNPs tended to have
a larger proportion of low allele frequencies compared
Distribution of the SNPs identified in the 81 candidate osteoporosis genes Figure 1
Distribution of the SNPs identified in the 81 candidate osteoporosis genes. (A) Classification of the SNPs into minor allele fre-
quency (MAF) classes. (B) Number of known and unknown SNPs. (C) Distribution of SNPs according to location or type. The 
percentages in (A), (B), and (C) refer to the percentage of SNPs within each MAF class in the given categories.
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with the synonymous cSNPs, the noncoding SNPs, and
the promoter SNPs. This trend is consistent with a selec-
tion pressure against SNPs that cause amino acid changes
[80]. In contrast, the promoter regions, which had a wide
range of allele frequencies overall, had more SNPs with
high allele frequency compared with the other regions.
These results indicate that the promoter variants found in
this study might be utilized as genetic determinants for
future studies [81]. The several million human SNPs
reported in the HapMap international project will likely
prove useful for association studies; however SNPs
located close to functionally important genes are more
valuable as markers than random genomic SNPs. Moreo-
ver, SNPs located in the coding or promoter regions have
the added benefit of potentially causing the genetic varia-
tion that directly contributes to disease. Therefore, addi-
tional resequencing efforts are still needed for
comprehensive studies of osteoporosis candidate genes
across ethnic groups as such data should prove important
for future association studies of osteoporosis.
Conclusion
We directly resequenced 81 candidate osteoporosis genes
and identified 942 variants including 888 SNPs, 43 inser-
tion/deletion polymorphisms, and 11 microsatellite
markers. Of the 888 SNPs, 331 SNPs have not been previ-
ously identified and 557 SNPs were already reported in
the dbSNP database, of which more than 460 were vali-
dated by our resequencing effort.
Statistical analysis of deviation in heterozygosity with the
HapMap data depicted that compared with SNPs in Kore-
ans, 1%(or less) of SNPs in Japanese and Chinese and
20% of those in Caucasian and African were significantly
differentiated from the Hardy-Weinberg expectations. In
addition, the analysis of genetic diversity between Korean
and the other four populations showed that the order of
the closest neighbor (in terms of genetic distance) is Han
Chinese, Japanese, African and Caucasian. In general, we
didn't find any significant differences among three sub-
populations from KR, CHB and JPT, but these Asian pop-
ulations, CEU and YRI were significantly different in both
the FST and genetic diversity results in selected genes. Nev-
ertheless, analysis using genetic properties, such as LD and
Distribution of FST among the sub-populations Figure 2
Distribution of FST among the sub-populations.
Fig. 2.
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Comparison of LD patterns of PTK2B and IL1RN among the sub-populations Figure 3
Comparison of LD patterns of PTK2B and IL1RN among the sub-populations.
Fig. 3.
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haplotype patterns showed that all-sub populations were
substantially different.
Overall, through the resequencing of 81 osteoporosis can-
didate genes, 118 unknown SNPs with MAF > 0.05 were
discovered in a Korean population. In addition, our newly
discovered SNPs were compared with those in HapMap to
elucidate diversity and deviation in heterozygosity, result-
ing in strong genetic linkages between the Han Chinese,
Japanese and Korean populations. This result may reflect
either a recent common ancestry or high levels of mutual
immigration among these groups. Yet, using a genetic
property, such as LD patterns, is a powerful method to
elucidate the subtle differences between the Korean, Chi-
nese and Japanese populations. Our results could aid in
the design of case-controlled and population stratification
studies in the Korean population.
Competing interests
The author(s) declare that they have no competing inter-
ests.
Authors' contributions
KS and GS performed genome sequence analysis, pro-
duced the results and drafted the manuscript. JY, HJ, MH,
HD and JH contributed to the preparation of samples and
sequence alignment in the study. KJ and HS provided
technical assistance. JS performed the statistical analysis
with FST and calculated the genetic distances between the
sub-populations and revised the manuscript. JM, EK and
TH selected the candidate genes involved in bone resorp-
tion using a microarray experiment and revised the man-
uscript. BS, KC and HL have been involved in critically
revising the manuscript for important intellectual con-
tent. JYL and SY contributed to the conception of the
study and participated in the interpretation of the results
and revision of the manuscript. All authors read and
approved the final manuscript.
Acknowledgements
This work was supported by intramural grants from the Korea National 
Institute of Health, Korea Center for Disease Control, Republic of Korea 
(Project No.: 347-6111-211) and a grant from the Korea Health 21 R&D 
Project, Ministry of Health & Welfare, Republic of Korea (Project No.: 
A010252)
References
1. Aubin JE, Triffit JT: Mesenchymal stem cells and osteoblast dif-
ferentiation.  In Principles of bone biology Volume 1. Edited by: Bilezi-
kian JP, Raisz LG, Rodan GA. San Diego: Academic Press; 2002:59-81. 
2. Theoleyre S, Wittrant Y, Tat SK, Fortun Y, Redini F, Heymann D:
The molecular triad OPG/RANK/RANKL: involvement in
the orchestration of pathophysiological bone remodeling.
Cytokine Growth Factor Rev 2004, 15:457-475. Review.
3. Pocock NA, Eisman JA, Hopper JL, Yeates MG, Sambrook PN, Eberl
S: Genetic determinants of bone mass in adults. A twin study.
J Clin Invest 1987, 80:706-10.
4. Slemenda CW, Christian JC, Williams CJ, Norton JA, Johnston CC Jr:
Genetic determinants of bone mass in adult women: A re-
evaluation of the twin model and the potential importance
of gene interaction on heritability estimates.  J Bone Miner Res
1991, 6:561-7.
5. Lutz J, Tesar R: Mother-daughter pairs: Spinal and femoral
bone densities and dietary intakes.  Am J Clin Nutr 1990,
52:872-877.
6. Guéguen R, Jouanny P, Guillemin F, Kuntz C, Pourel J, Siest G: Seg-
regation analysis and variance components analysis of bone
mineral density in healthy families.  J Bone Miner Res 1995,
10(12):2017-2022.
7. Hunter DJ, de Lange M, Andrew T, Snieder H, Mac-Gregor AJ, Spec-
tor TD: Genetic variation in bone mineral density and calca-
neal ultrasound: a study of the influence of menupause using
female twins.  Osteoporos Int 2001, 12:406-11.
8. Ng MY, Sham PC, Paterson AD, Chan V, Kung AW: Effect of envi-
ronmental factors and gender on the heritability of bone
mineral density and bone size.  Ann Hum Genet 2006, 70:428-38.
9. Wang YB, Guo JJ, Liu YJ, Deng FY, Jiang DK, Deng HW: The human
calcium-sensing receptor and interleukin-6 genes are associ-
ated with bone mineral density in Chinese.  Yi Chuan Xue Bao
2006, 33:870-80.
10. Beavan S, Prentice A, Dibba B, Yan L, Coper C, Ralston SH: Poly-
morphism of the collagen type I α1 gene and ethnic differ-
ences in hip-fracture rates.  N Engl J Med 1998, 339:351-352.
11. Dvornyk V, Liu XH, Shen H, Lei SF, Zhao LJ, Huang QR, Qin YJ, Jiang
DK, Long JR, Zhang YY, Gong G, Recker RR, Deng HW: Differenti-
ation of Caucasians and Chinese at bone mass candidate
genes: implication for ethnic difference of bone mass.  Ann
Hum Genet 2003, 67:216-27.
12. Hwang JY, Lee JY, Park MH, Kim KS, Kim KK, Ryu HJ, Lee JK, Han BG,
Kim JW, Oh B, Kimm K, Park BL, Shin HD, Kim TH, Hong JM, Park
EK, Kim DJ, Koh JM, Kim GS, Kim SY: Association of PLXNA2
polymorphisms with vertebral fracture risk and bone min-
eral density in postmenopausal Korean population.  Oste-
oporos Int 2006, 17:1592-601.
13. Oh B, Kim SY, Kim DJ, Lee JY, Lee JK, Kimm K, Park BL, Shin HD, Kim
TH, Park EK, Koh JM, Kim GS: Associations of catalase gene pol-
ymorphisms with bone mineral density and bone turnover
markers in postmenopausal women.  J Med Genet 2007, 44:e62.
14. Koh JM, Oh B, Lee JY, Lee JK, Kimm K, Kim GS, Park BL, Cheong HS,
Shin HD, Hong JM, Kim TH, Park EK, Kim SY: Association study of
semaphorin 7a (sema7a) polymorphisms with bone mineral
density and fracture risk in postmenopausal Korean women.
J Hum Genet 2006, 51:112-7.
15. de Crombrugghe B, Lefebvre V, Nakashima K: Regulatory mecha-
nisms in the pathways of cartilage and boneformation.  Curr
Opin Cell Biol 2001, 13:721-7. Review.
16. Kobayashi T, Kronenberg H: Minireview: transcriptional regula-
tion in development of bone.  Endocrinology 2005, 146:1012-7.
Review.
17. Ortega N, Behonick DJ, Colnot C, Cooper DN, Werb Z: Galectin-
3 is a downstream regulator of matrix metalloproteinase-9
function during endochondral bone formation.  Mol Biol Cell
2005, 16:3028-39.
18. Andersen H, Jensen ON, Moiseeva EP, Eriksen EF: A proteome
study of secreted prostatic factors affecting osteoblastic
activity: galectin-1 is involved in differentiation of human
bone marrow stromal cells.  J Bone Miner Res 2003, 18:195-203.
Table 3: Pairwise genetic distance among five population
KOR CHB JPT CEU YRI
KOR 0.01197 0.01331 0.64578 0.59374
CHB 0.05259 0.01207 0.68158 0.58691
JPT 0.05775 0.04840 0.71527 0.60823
CEU 0.85137 0.86316 0.86480 1.00000
YRI 0.83252 0.82958 0.83475 1.00000
The upper triangle is for Nei's standard genetic distance [19] and the 
lower triangle is for Latter's FST distance [20].BMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
Page 12 of 13
(page number not for citation purposes)
19. Harada S, Rodan GA: Control of osteoblast function and regu-
lation of bone mass.  Nature 2003, 423:349-55. Review.
20. Yoshida CA, Furuichi T, Fujita T, Fukuyama R, Kanatani N, Kobayashi
S, Satake M, Takada K, Komori T: Core-binding factor beta inter-
acts with Runx2 and is required for skeletal development.
Nat Genet 2002, 32:633-8.
21. Zhou S, Glowacki J, Yates KE: Comparison of TGF-beta/BMP
pathways signaled by demineralized bone powder and BMP-
2 in human dermal fibroblasts.  J Bone Miner Res 2004,
19:1732-41.
22. Zhang Z, Song Y, Zhang X, Tang J, Chen J, Chen Y: Msx1/Bmp4
genetic pathway regulates mammalian alveolar bone forma-
tion via induction of Dlx5 and Cbfa1.  Mech Dev 2003,
120:1469-79.
23. Pagani F, Francucci CM, Moro L: Markers of bone turnover: bio-
chemical and clinical perspectives.  J Endocrinol Invest 2005,
28(10 Suppl):8-13. Review.
24. Jabs EW: A TWIST in the fate of human osteoblasts identifies
signaling molecules involved in skull development.  J Clin Invest
2001, 107:1075-7.
25. Nemetz A, Toth M, Garcia-Gonzalez MA, Zagoni T, Feher J, Pena AS,
Tulassay Z: Allelic variation at the interleukin 1beta gene is
associated with decreased bone mass in patients with inflam-
matory bowel diseases.  Gut 2001, 49:644-9.
26. Raisz LG: Pathogenesis of osteoporosis: concepts, conflicts,
and prospects.  J Clin Invest 2005, 115:3318-25.
27. Bienz M, Clevers H: Linking colorectal cancer to Wnt signaling.
Cell 2000, 103:311-20. Review
28. Tasheva ES, Klocke B, Conrad GW: Analysis of transcriptional
regulation of the small leucine rich proteoglycans.  Mol Vis
2004, 10:758-72.
29. Deckers MM, Karperien M, van der Bent C, Yamashita T, Papapoulos
SE, Lowik CW: Expression of vascular endothelial growth fac-
tors and their receptors during osteoblast differentiation.
Endocrinology 2000, 141:1667-74.
30. Ye L, Mishina Y, Chen D, Huang H, Dallas SL, Dallas MR, Sivakumar
P, Kunieda T, Tsutsui TW, Boskey A, Bonewald LF, Feng JQ: Dmp1-
deficient mice display severe defects in cartilage formation
responsible for a chondrodysplasia-like phenotype.  J Biol Chem
2005, 280:6197-203.
31. Rifas L, Cheng SL: IL-13 regulates vascular cell adhesion mole-
cule-1 expression in human osteoblasts.  J Cell Biochem 2003,
89:213-9.
32. Yanase T, Suzuki S, Goto K, Nomura M, Okabe T, Takayanagi R,
Nawata H: Aromatase in bone: roles of Vitamin D3 and andro-
gens.  J Steroid Biochem Mol Biol 2003, 86:393-7. Review.
33. Somner J, McLellan S, Cheung J, Mak YT, Frost ML, Knapp KM, Wierz-
bicki AS, Wheeler M, Fogelman I, Ralston SH, Hampson GN: Poly-
morphisms in the P450 c17 (17-hydroxylase/17,20-Lyase)
and P450 c19 (aromatase) genes: association with serum sex
steroid concentrations and bone mineral density in post-
menopausal women.  J Clin Endocrinol Metab 2004, 89:344-51.
34. Voskaridou E, Terpos E: New insights into the pathophysiology
and management of osteoporosis in patients with beta tha-
lassaemia.  Br J Haematol 2004, 127:127-39. Review.
35. Szweras M, Liu D, Partridge EA, Pawling J, Sukhu B, Clokie C, Jahnen-
Dechent W, Tenenbaum HC, Swallow CJ, Grynpas MD, Dennis JW:
alpha 2-HS glycoprotein/fetuin, a transforming growth fac-
tor-beta/bone morphogenetic protein antagonist, regulates
postnatal bone growth and remodeling.  J Biol Chem 2002,
277:19991-7.
36. Parisi MS, Gazzerro E, Rydziel S, Canalis E: Expression and regula-
tion of CCN genes in murine osteoblasts.  Bone 2006, 38:671-7.
37. Vaes BL, Dechering KJ, van Someren EP, Hendriks JM, van de Ven CJ,
Feijen A, Mummery CL, Reinders MJ, Olijve W, van Zoelen EJ,
Steegenga WT: Microarray analysis reveals expression regula-
tion of Wnt antagonists in differentiating osteoblasts.  Bone
2005, 36:803-11.
38. Nampei A, Hashimoto J, Hayashida K, Tsuboi H, Shi K, Tsuji I, Miyas-
hita H, Yamada T, Matsukawa N, Matsumoto M, Morimoto S, Ogihara
T, Ochi T, Yoshikawa H: Matrix extracellular phosphoglycopro-
tein (MEPE) is highly expressed in osteocytes in human
bone.  J Bone Miner Metab 2004, 22:176-84.
39. Van Vlasselaer P, Borremans B, Van Den Heuvel R, Van Gorp U, de
Waal Malefyt R: Interleukin-10 inhibits the osteogenic activity
of mouse bone marrow.  Blood 1993, 82:2361-70.
40. Van Vlasselaer P, Borremans B, van Gorp U, Dasch JR, De Waal-Male-
fyt R: Interleukin 10 inhibits transforming growth factor-beta
(TGF-beta) synthesis required for osteogenic commitment
of mouse bone marrow cells.  J Cell Biol 1994, 124:569-77.
41. Blair HC, Robinson LJ, Zaidi M: Osteoclast signalling pathways.
Biochem Biophys Res Commun 2005, 328:728-38. Review.
42. Teitelbaum SL: Bone resorption by osteoclasts.  Science 2000,
289:1504-8. Review.
43. Titelbaum SL: Osteoporosis and integrins.  J Clin Endocrinol Metab
2005, 90:2466-2468.
44. Boyle WJ, Simonet WS, Lacey DL: Osteoclast differentiation and
activation.  Nature 2003, 423:337-42. Review.
45. Ito Y, Inoue D, Kido S, Matsumoto T: c-Fos degradation by the
ubiquitin-proteasome proteolytic pathway in osteoclast pro-
genitors.  Bone 2005, 37:842-9.
46. Takayanagi H, Kim S, Matsuo K, Suzuki H, Suzuki T, Sato K, Yokochi
T, Oda H, Nakamura K, Ida N, Wagner EF, Taniguchi T: RANKL
maintains bone homeostasis through c-Fos-dependent
induction of interferon-beta.  Nature 2002, 416:744-9.
47. Chang W, Rewari A, Centrella M, McCarthy TL: Fos-related anti-
gen 2 controls protein kinase A-induced CCAAT/enhancer-
binding protein beta expression in osteoblasts.  J Biol Chem
2004, 279:42438-44.
48. Ishida N, Hayashi K, Hattori A, Yogo K, Kimura T, Takeya T: CCR1
acts downstream of NFAT2 in osteoclastogenesis and
enhances cell migration.  J Bone Miner Res 2006, 21:48-57.
49. Koga T, Matsui Y, Asagiri M, Kodama T, de Crombrugghe B,
Nakashima K, Takayanagi H: NFAT and Osterix cooperatively
regulate bone formation.  Nat Med 2005, 11:880-5.
50. Kawaida R, Ohtsuka T, Okutsu J, Takahashi T, Kadono Y, Oda H,
Hikita A, Nakamura K, Tanaka S, Furukawa H: Jun dimerization
protein 2 (JDP2), a member of the AP-1 family of transcrip-
tion factor, mediates osteoclast differentiation induced by
RANKL.  J Exp Med 2003, 197:1029-35.
51. Ogata Y, Kukita A, Kukita T, Komine M, Miyahara A, Miyazaki S,
Kohashi O: A novel role of IL-15 in the development of osteo-
clasts: inability to replace its activity with IL-2.  J Immunol 1999,
162:2754-60.
52. Lakkakorpi PT, Bett AJ, Lipfert L, Rodan GA, Duong le T: PYK2
autophosphorylation, but not kinase activity, is necessary for
adhesion-induced association with c-Src, osteoclast spread-
ing, and bone resorption.  J Biol Chem 2003, 278:11502-12.
53. Kameda T, Mano H, Yamada Y, Takai H, Amizuka N, Kobori M, Izumi
N, Kawashima H, Ozawa H, Ikeda K, Kameda A, Hakeda Y, Kumeg-
awa M: Calcium-sensing receptor in mature osteoclasts,
which are bone resorbing cells.  Biochem Biophys Res Commun
1998, 245:419-22.
54. Delorme G, Saltel F, Bonnelye E, Jurdic P, Machuca-Gayet I: Expres-
sion and function of semaphorin 7A in bone cells.  Biol Cell
2005, 97:589-97.
55. Miyaura C, Inada M, Suzawa T, Sugimoto Y, Ushikubi F, Ichikawa A,
Narumiya S, Suda T: Impaired bone resorption to prostaglandin
E2 in prostaglandin E receptor EP4-knockout mice.  J Biol
Chem 2000, 275:19819-23.
56. Khapli SM, Mangashetti LS, Yogesha SD, Wani MR: IL-3 acts directly
on osteoclast precursors and irreversibly inhibits receptor
activator of NF-kappa B ligand-induced osteoclast differenti-
ation by diverting the cells to macrophage lineage.  J Immunol
2003, 171:142-51.
57. Shin JN, Kim I, Lee JS, Koh GY, Lee ZH, Kim HH: A novel zinc fin-
ger protein that inhibits osteoclastogenesis and the function
of tumor necrosis factor receptor-associated factor 6.  J Biol
Chem 2002, 277:8346-53.
58. Lean JM, Jagger CJ, Kirstein B, Fuller K, Chambers TJ: Hydrogen
peroxide is essential for estrogen-deficiency bone loss and
osteoclast formation.  Endocrinology 2005, 146:728-35.
59. Fujimiya K, Sugihara K, Nishikawa T: Experimental study on the
role of osteoclasts and free radicals in the mandibular inva-
sion of VX2 carcinoma in Japanese white rabbits.  Bone 1997,
20:245-50.
60. Sandberg MB, Bloksgaard M, Duran-Sandoval D, Duval C, Staels B,
Mandrup S: The gene encoding acyl-CoA-binding protein is
subject to metabolic regulation by both sterol regulatory
element-binding protein and peroxisome proliferator-acti-
vated receptor alpha in hepatocytes.  J Biol Chem 2005,
280:5258-66.Publish with BioMed Central    and   every 
scientist can read your work free of charge
"BioMed Central will be the most significant development for 
disseminating the results of biomedical research in our lifetime."
Sir Paul Nurse, Cancer Research UK
Your research papers will be:
available free of charge to the entire biomedical community
peer reviewed and published  immediately upon acceptance
cited in PubMed and archived on PubMed Central 
yours — you keep the copyright
Submit your manuscript here:
http://www.biomedcentral.com/info/publishing_adv.asp
BioMedcentral
BMC Medical Genetics 2007, 8:70 http://www.biomedcentral.com/1471-2350/8/70
Page 13 of 13
(page number not for citation purposes)
61. Rozen S, Skaletsky H: Primer3 on the WWW for general users
and for biologist programmers.  Methods Mol Biol 2000,
132:365-386.
62. Ewing B, Hillier L, Wendl MC, Green P: Base-calling of automated
sequencer traces using phred. I. Accuracy assessment.
Genome Res 1998, 8:175-185.
63. Gordon D, Abajian C, Green P: Consed: a graphical tool for
sequence finishing.  Genome Res 1998, 8:195-202.
64. Nickerson DA, Tobe VO, Taylor SL: PolyPhred: automating the
detection and genotyping of single nucleotide substitutions
using fluorescence-based resequencing.  Nucleic Acids Res 1997,
25:2745-2751.
65. KSNP database   [http://www.ngri.re.kr/SNP/]
66. International HapMap Project   [http://www.hapmap.org/
index.html.en/]
67. Qin ZS, Niu T, Liu JS: Partition-ligation-expectation maximiza-
tion algorithm for haplotype inference with singlenucleotide
polymorphisms.  Am J Hum Genet 2002, 71:1242-1247.
68. Zhu X, Yan D, Cooper RS, Luke A, Ikeda MA, Chang YP, Weder A,
Chakravarti A: Linkage disequilibrium and haplotype diversity
in the genes of the renin-angiotensin system: findings from
the family blood pressure program.  Genome Res 2003,
13:173-81.
69. Avi-Itzhak HI, Su X, De La Vega FM: Selection of minimum sub-
sets of single nucleotide polymorphisms to capture haplo-
type block diversity.  Pac Symp Biocomput 2003:466-77.
70. Cargill M, Altshuler D, Ireland J, Sklar P, Ardlie K, Patil N, Shaw N,
Lane CR, Lim EP, Kalyanaraman N, Nemesh J, Ziaugra L, Friedland L,
Rolfe A, Warrington J, Lipshutz R, Daley GQ, Lander ES: Character-
ization of single-nucleotide polymorphisms in coding regions
of human genes.  Nat Genet 1999, 22:231-8.
71. A database of Japanese Single Nucleotide Polymorphisms
[http://snp.ims.u-tokyo.ac.jp/]
72. Barrett JC, Fry B, Maller J, Daly MJ: Haploview: analysis and visu-
alization of LD and haplotype maps.  Bioinformatics 2005,
21:263-5.
73. Gabriel SB, Schaffner SF, Nguyen H, Moore JM, Roy J, Blumenstiel B,
Higgins J, DeFelice M, Lochner A, Faggart M, Liu-Cordero SN, Rotimi
C, Adeyemo A, Cooper R, Ward R, Lander ES, Daly MJ, Altshuler D:
The structure of haplotype blocks in the human genome.  Sci-
ence 2002, 296:2225-9.
74. The International HapMap Consortium: The International Hap-
Map Project.  Nature 2003, 426:789-796.
75. Wright S: Evolution and the Genetics of populations IV: vari-
ability within and among natural populations.  Chicago: Uni-
versity of Chicago Press; 1978. 
76. Hartl D, Clark AG: Principles of population genetics.  Sunder-
land, MA: Sinauer Associates; 1989:118-119. 
77. Nei M, Roychoudhury AK: Sampling variances of heterozygos-
ity and genetic distance.  Genetics 1974, 76:379-90.
78. Latter BD: Selection in finite populations with multiple alleles.
3. Genetic divergence with centripetal selection and muta-
tion.  Genetics 1972, 70:475-90.
79. Kim KJ, Lee HJ, Park MH, Cha SH, Kim KS, Kim HT, Kimm K, Oh B,
Lee JY: SNP identification, linkage disequilibrium, and haplo-
type analysis for a 200-kb genomic region in a Korean popu-
lation.  Genomics 2006, 88:535-40.
80. Kim JJ, Kim HH, Park JH, Ryu HJ, Kim J, Moon S, Gu H, Kim HT, Lee
JY, Han BG, Park C, Kimm K, Park CS, Lee JK, Oh B: Large-scale
identification and characterization of genetic variants in
asthma candidate genes.  Immunogenetics 2005, 57:636-43.
81. Kim GS, Koh JM, Chang JS, Park BL, Kim LH, Park EK, Kim SY, Shin
HD:  Association of the OSCAR promoter polymorphism
with BMD in postmenopausal women.  J Bone Miner Res 2005,
20:1342-8.
Pre-publication history
The pre-publication history for this paper can be accessed
here:
http://www.biomedcentral.com/1471-2350/8/70/prepub